Ditchcarbon
  • Contact
  1. Organizations
  2. RBC Life Sciences, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 months ago

RBC Life Sciences, Inc. Sustainability Profile

Company website

RBC Life Sciences, Inc., a prominent player in the biotechnology and life sciences sector, is headquartered in the United States. Founded in 1997, the company has established itself as a leader in the development and distribution of innovative health products, particularly in the fields of nutritional supplements and diagnostic testing. With a focus on enhancing health and wellness, RBC Life Sciences offers a unique range of core products, including proprietary formulations that cater to various health needs. The company’s commitment to quality and scientific research has positioned it favourably in the competitive life sciences market. Notable achievements include significant advancements in product efficacy and a growing presence in key operational regions across North America.

DitchCarbon Score

How does RBC Life Sciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

29

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

RBC Life Sciences, Inc.'s score of 29 is lower than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.

49%

Let us know if this data was useful to you

RBC Life Sciences, Inc.'s reported carbon emissions

RBC Life Sciences, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures. However, the company has established significant climate commitments aimed at reducing its carbon footprint. RBC Life Sciences has set a near-term target to achieve a 36% reduction in absolute emissions for both Scope 1 and Scope 2 by 2030, using 2020 as the baseline year. This aligns with broader trends observed in developed economies, including the EU and the US, which are also targeting similar reductions. In addition to these near-term goals, RBC Life Sciences has long-term net-zero commitments for Scope 1 and Scope 2 emissions, with a target year extending to 2060. This commitment reflects the company's alignment with emerging global standards and initiatives aimed at combating climate change. While specific emissions data is not available, RBC Life Sciences' proactive approach to setting reduction targets demonstrates its commitment to sustainability and climate responsibility.

How Carbon Intensive is RBC Life Sciences, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. RBC Life Sciences, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is RBC Life Sciences, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for RBC Life Sciences, Inc. is in US, which has a low grid carbon intensity relative to other regions.

RBC Life Sciences, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

RBC Life Sciences, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare RBC Life Sciences, Inc.'s Emissions with Industry Peers

Shaklee Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Intrexon Bioinformatics Germany GmbH

DE
•
Computer and related services (72)
Updated 3 months ago

GNC Holdings, Inc.

US
•
Food products nec
Updated 14 days ago

Illumina

US
•
Research and development services (73)
Updated 2 days ago

Reliv' International, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Herbalife

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Let us know if this data was useful to you

Usage Policy

You're welcome to quote or reference data from this page, but please include a visible link back to this URL.

Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.

See our License Agreement for more details.

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251211.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
Use CaseSBTi-aligned baselining & progress trackingSupplier EngagementClimate-informed sourcing strategyEmission ReportingSustainable Finance
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelogWhitepaper
AboutTeamCareersLicense AgreementPrivacy